These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34597441)

  • 21. Molecular insights into paediatric breast fibroepithelial tumours.
    Tay TKY; Guan P; Loke BN; Nasir NDM; Rajasegaran V; Thike AA; Lian D; Chang KTE; Teh BT; Ng CCY; Tan PH
    Histopathology; 2018 Nov; 73(5):809-818. PubMed ID: 29969836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.
    Ng CCY; Md Nasir ND; Loke BN; Tay TKY; Thike AA; Rajasegaran V; Liu W; Lee JY; Guan P; Lim AH; Chang KTE; Gudi MA; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Yip GWC; Bay BH; Tan P; Teh BT; Tan PH
    Mod Pathol; 2021 Jul; 34(7):1320-1332. PubMed ID: 33727697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
    Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
    J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.
    Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK
    Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing.
    Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2015 Jul; 152(2):305-12. PubMed ID: 26093648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathological features and clinicopathological significance of TERT promoter mutation in breast fibroepithelial tumors without definite diagnosis].
    Wang JG; Hu YJ; Guan JJ; Liu HY; Bi ZJ; Zhang LX; Liu YX; Xing XM
    Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):153-159. PubMed ID: 36748136
    [No Abstract]   [Full Text] [Related]  

  • 27. Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways.
    Pareja F; Geyer FC; Kumar R; Selenica P; Piscuoglio S; Ng CKY; Burke KA; Edelweiss M; Murray MP; Brogi E; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2017; 3():40. PubMed ID: 29043292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
    Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
    Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women.
    Darooei M; Khan F; Rehan M; Zubeda S; Jeyashanker E; Annapurna S; Shah A; Maddali S; Hasan Q
    J Cell Biochem; 2019 Jan; 120(1):182-191. PubMed ID: 30230586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.
    Lim WK; Ong CK; Tan J; Thike AA; Ng CC; Rajasegaran V; Myint SS; Nagarajan S; Nasir ND; McPherson JR; Cutcutache I; Poore G; Tay ST; Ooi WS; Tan VK; Hartman M; Ong KW; Tan BK; Rozen SG; Tan PH; Tan P; Teh BT
    Nat Genet; 2014 Aug; 46(8):877-80. PubMed ID: 25038752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
    Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
    BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins.
    Cowan ML; Argani P; Cimino-Mathews A
    Mod Pathol; 2016 Mar; 29(3):259-65. PubMed ID: 26743469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
    Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
    Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.
    Yoon N; Bae GE; Kang SY; Choi MS; Hwang HW; Kim SW; Lee JE; Nam SJ; Gong G; Lee HJ; Bae YK; Lee A; Cho EY
    Genes Chromosomes Cancer; 2016 Jun; 55(6):495-504. PubMed ID: 26856273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
    Cani AK; Hovelson DH; McDaniel AS; Sadis S; Haller MJ; Yadati V; Amin AM; Bratley J; Bandla S; Williams PD; Rhodes K; Liu CJ; Quist MJ; Rhodes DR; Grasso CS; Kleer CG; Tomlins SA
    Mol Cancer Res; 2015 Apr; 13(4):613-9. PubMed ID: 25593300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.
    Piscuoglio S; Geyer FC; Burke KA; Murray MP; Ng CK; Mota A; Marchio C; Berman SH; Norton L; Brogi E; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2016; 2():16035. PubMed ID: 28721388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Diagnostic Approach to Fibroepithelial Breast Lesions.
    Tan BY; Tan PH
    Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
    Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
    Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.